Elon Musk’s Neuralink announced on Wednesday that it has obtained approval to conduct its first clinical trial in Canada. The trial will focus on a device designed to enable paralysed individuals to control digital devices through thought alone.
The study will evaluate the safety and initial functionality of Neuralink’s implant, which aims to assist individuals with quadriplegia—paralysis of all four limbs—in using external devices via thought control.
NigeriaDNA is a Direct News source that delivers the latest news, buzz, and stories from some of Nigeria’s most popular and trusted news websites. NigeriaDNA facilitates this by publishing headlines linking to breaking news and curated snippets from a diverse range of Nigerian credible, independent, and public-interest news sources. Our editors make it easy for Nigerians abroad and diaspora to discover top news stories in real-time as they're posted and directly linked to Nigeria's authoritative News Sources.
© 2024 All Rights Reserved | Curated and Powered by Nigeria DNA
